Survivin signaling in clinical oncology: a multifaceted dragon. - Wikidata - wikimedia - TriplyDB

Survivin signaling in clinical oncology: a multifaceted dragon.

Survivin signaling in clinical oncology: a multifaceted dragon.

http://www.wikidata.org/entity/Q38017923

about

Survivin: A molecular biomarker in cancer Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery Nanoformulated cell-penetrating survivin mutant and its dual actions.Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.MicroRNA regulation and therapeutic targeting of survivin in cancer.Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model.The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.In vivo induction of apoptosis by fucoxanthin, a marine carotenoid, associated with down-regulating STAT3/EGFR signaling in sarcoma 180 (S180) xenografts-bearing mice.Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.Nanotechnology based platforms for survivin targeted drug discovery.Monitoring survivin expression in cancer: implications for prognosis and therapy.Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery.miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.Epigenetic mechanism of survivin dysregulation in human cancer.Recent advances in nanomedicine and survivin targeting in brain cancers.Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.Effects of HSYA on the proliferation and apoptosis of MSCs exposed to hypoxic and serum deprivation conditions.MicroRNA-195: a review of its role in cancers

P2860

Q26823439-B7954A22-9AC0-4CA9-8120-C765C1AFD628 Q28652407-848A214E-C353-4314-9FBB-A601E4DE5252 Q33904982-A9383EE8-44A6-4F00-82C2-D45CA6A568A6 Q34062021-226DD44B-4729-4694-8A6F-FD79CE59B1B7 Q34991312-DAFA8416-9E3A-497B-8DE0-0CE1B705E00B Q35073199-19485F20-1531-4CDB-97AB-E3CEDA430F71 Q35092566-36CD9F3C-ECAC-4193-989F-96EFCFC5A440 Q35849951-F6F21C01-4E75-4FE5-B5FB-C93C65782530 Q35914683-EBDE5EDA-EE20-425D-BE3F-A6609219B74A Q36329883-9EE2E909-9060-4B20-9F64-9A457915AF43 Q36338764-5E7811DD-BF35-42DE-BCB9-72AF11779A68 Q36413716-0D2EDFBC-A19C-40C8-AB9B-427570DAEC89 Q36776653-7C0A4012-1F0D-41E4-AE3A-AB076459D93B Q37437269-FFD8D27C-6F10-4C50-87F4-CEE8DA727429 Q38040859-E11DF17F-AAE4-49EE-9DB4-22DF516097BB Q38126394-A5B7AF63-4202-438A-BF39-221CA0A4A4A5 Q38188591-B420C6D2-D20F-4065-9DDC-50522C9A6010 Q38300295-D0E4AAE8-9912-48F0-BC8E-F08F3C5A97D5 Q38602174-B8378117-8A1A-43DF-A013-996EEA1A99B3 Q38811077-2364D32A-38A1-4847-9D6E-F3D6274BFC82 Q38883702-28626465-63C4-4ED2-8DA0-32EDF6227745 Q38924340-3F72899B-DC10-42CD-8490-593DD38A4CA5 Q38985281-15AA50C4-CE90-45F6-8D70-06D140746E49 Q39432577-6CD240A9-0F14-43AC-9FC4-8858C1868AEA Q47215045-7E203DEF-C120-423F-BDBA-E7C7676290E7 Q47378913-C9D998C7-8532-4B54-9596-3C54B6EFF883 Q49590876-FAA2574C-428A-4F92-B1F4-76B7DC6C6321 Q55406358-F0AA940F-92F6-4AE4-8BAB-81F2533D635A Q58547821-C1E43434-DA67-4160-8080-D83AFAD5F97E

P2860

Survivin signaling in clinical oncology: a multifaceted dragon.

http://www.wikidata.org/entity/Q38017923

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Survivin signaling in clinical oncology: a multifaceted dragon.

@en

type

label

Survivin signaling in clinical oncology: a multifaceted dragon.

@en

prefLabel

Survivin signaling in clinical oncology: a multifaceted dragon.

@en

P1433

Q38017923-B8A52B4C-7696-4CA6-921E-D9FAEF20BD48

P1476

Q38017923-A251830D-77BA-4F2D-8B38-9B9FDFD36BA8

P2093

Q38017923-33A382EC-1E66-4539-8D8F-9E0D4233B57E

Q38017923-81E4FB6C-943C-4A5E-AD7E-5371D10A8A62

P2860

Q38017923-006CBC87-A7ED-4505-BF75-F34E95ABA812

Q38017923-0116F216-1CC1-41AA-9115-262996549AB3

Q38017923-129A8403-7851-45EB-8748-E24A6AA0BF2D

Q38017923-14A7308A-CD2F-45B0-8FAF-9D41A77C0411

Q38017923-1516DA14-E630-4FB8-9CED-3359662419FD

Q38017923-16F15379-C518-4A42-8F7B-7DCA7CA76156

Q38017923-1BCC1F49-E64E-46A7-849F-76EABB284A84

Q38017923-1F16B565-FBBA-4DFC-9EFA-89BABDEFC7B5

Q38017923-21C6EB7A-E66F-40DD-BD69-D3EB17767AA8

Q38017923-23E70E90-059B-4119-8306-D1F685A7E3C5

P304

Q38017923-26D40897-97E5-45FF-8834-F6D65413ED46

P31

Q38017923-CFD25FEF-108F-4B22-BF3F-858A0AFB7C15

P356

Q38017923-8457CD3A-95A8-451D-AB65-04DF996D003A

P433

Q38017923-55120E07-148D-4250-A609-E3CB31A9FE12

P478

Q38017923-707FE52A-7AC1-4A91-942C-F4E0E10B9B8C

P50

Q38017923-6DE0A50E-FAE6-471E-808A-15A37043C3B9

P577

Q38017923-D38B9605-7A94-4C93-B013-84DB6AB72B66

P698

Q38017923-7FDDFC09-7599-440D-9C5A-48E0022C40CD

P356

P1433

Medicinal Research Reviews

P1476

Survivin signaling in clinical oncology: a multifaceted dragon.

@en

P2093

Rupinder K Kanwar

http://www.w3.org/2001/XMLSchema#string

Sishir K Kamalapuram

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting survivin in cancer therapy: fulfilled promises and open questions

Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.

Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.

Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors.

Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components.

Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers

Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival.

Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).

Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.

P304

765-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MED.21264

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22688671

http://www.w3.org/2001/XMLSchema#string